Toronto Dominion Bank’s AbbVie ABBV Stock Holding History

Toronto Dominion Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Hold	10,000	–	–	﹤0.01%	1117
2025 Q4	$2.28M	Hold	10,000	–	–	﹤0.01%	1082
2025 Q3	$2.32M	Buy	+10,000	New	+$2.04M	﹤0.01%	1007
2020 Q1	–	Sell	-110,000	Closed	-$9.74M	–	1228
2019 Q4	$9.74M	Buy	+110,000	New	+$9.13M	0.02%	485
2019 Q3	–	Sell	-312,600	Closed	-$11.4M	–	1436
2019 Q2	$11.4M	Buy	312,600 +288,600	+1,203%	+$22.7M	0.02%	443
2019 Q1	$1.93M	Buy	24,000 +23,000	+2,300%	+$1.88M	﹤0.01%	831
2018 Q4	$92K	Buy	+1,000	New	+$87.9K	﹤0.01%	1166

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Toronto Dominion Bank's ABBV Position: Q1 2026 in Review

Toronto Dominion Bank reduced its AbbVie (ABBV) stake by 50% in Q1 2026, selling an estimated $120M and leaving 538,014 shares worth $117M. The position accounts for 0.17% of the portfolio, ranked #110.

Toronto Dominion Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $247M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Toronto Dominion Bank held 538,014 shares of AbbVie worth $117M as of Q1 2026.
Toronto Dominion Bank sold 542,834 AbbVie shares in Q1 2026, an estimated $120M.
AbbVie made up 0.17% of Toronto Dominion Bank's portfolio in Q1 2026, its #110 holding.
Toronto Dominion Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's AbbVie position peaked at $247M in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.